arrow
T

Triparna Sen

the ohio state university comprehensive cancer center
H指数:38
被引数:7,407

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025

肺癌护理中的当前挑战与新兴治疗策略:Bridging the Gaps 2025的见解

Cancer
IF5.1
2026-09-290
PRE
Targeting NHEJ activates STING signaling through MYC degradation to boost antitumor immunity in SCLC

靶向NHEJ通过MYC降解激活STING信号通路以增强SCLC的抗肿瘤免疫

2026-02-100
OAAI
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer (vol 5, 101852, 2024)

Lurbinectedin通过激活STING-IFN信号通路使PD-L1阻断疗法增敏(vol 5, 101852, 2024)

2025-02-010
OAAI
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer

Lurbinectedin通过激活STING-IFN信号通路使小细胞肺癌对PD-L1阻断疗法产生增敏作用。

2024-12-012
PRE
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer
2024-09-271
OAAI